Skip to main content
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.730
-0.010 (-0.57%)
At close: Mar 9, 2026, 4:00 PM EDT
1.770
+0.040 (2.31%)
After-hours: Mar 9, 2026, 7:59 PM EDT

Inovio Pharmaceuticals Revenue

Inovio Pharmaceuticals had revenue of $182.34K in the twelve months ending September 30, 2025, down -10.36% year-over-year. In the year 2024, Inovio Pharmaceuticals had annual revenue of $217.76K, down -73.83%.

Revenue (ttm)
$182.34K
Revenue Growth
-10.36%
P/S Ratio
651.85
Revenue / Employee
$1,361
Employees
134
Market Cap
118.86M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024217.76K-614.25K-73.83%
Dec 31, 2023832.01K-9.43M-91.89%
Dec 31, 202210.26M8.49M478.23%
Dec 31, 20211.77M-5.64M-76.05%
Dec 31, 20207.41M3.30M80.24%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Codexis 52.93M
Gossamer Bio 44.05M
Coya Therapeutics 3.99M
Precision BioSciences 698.00K
Cardiff Oncology 593.00K
Genelux 8.00K
Revenue Rankings

INO News

More News